Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty (THA): Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH)

NCT00358735 is registered in ClinicalTrials.gov with Medical Compression Systems as lead sponsor.

NCT NCT00358735
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00358735 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty (THA): Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH)
Lead sponsor
Medical Compression Systems
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2006
Completion date
December 31, 2008
Enrollment
411 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding, deep vein thrombosis of lower limb, pulmonary embolism (pe)